Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Calcium binding EGF domain containing protein | 0.0078 | 0.1833 | 0.854 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0703 | 0.0703 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.1441 | 0.1441 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0042 | 0.0061 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0409 | 0.0409 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0127 | 0.4262 | 0.3828 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.1441 | 0.1441 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.0078 | 0.1833 | 0.1833 |
Schistosoma mansoni | egf-like domain protein | 0.007 | 0.1441 | 0.1441 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.1833 | 0.1833 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8162 | 0.8162 |
Onchocerca volvulus | Matrilysin homolog | 0.0077 | 0.1799 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0077 | 0.1799 | 0.1799 |
Brugia malayi | Matrixin family protein | 0.0084 | 0.2146 | 1 |
Brugia malayi | Low-density lipoprotein receptor repeat class B containing protein | 0.007 | 0.1441 | 0.6715 |
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.2855 | 0.2855 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0042 | 0.0061 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0951 | 0.4431 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0241 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.8162 | 0.8023 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8162 | 0.8162 |
Loa Loa (eye worm) | hypothetical protein | 0.0232 | 0.951 | 0.951 |
Loa Loa (eye worm) | AStacin protease | 0.0151 | 0.5482 | 0.5482 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0083 | 0.2072 | 0.2072 |
Loa Loa (eye worm) | matrixin family protein | 0.0084 | 0.2146 | 0.2146 |
Echinococcus granulosus | laminin | 0.0078 | 0.1833 | 0.1215 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0703 | 0.0703 |
Loa Loa (eye worm) | low-density lipoprotein receptor repeat class B containing protein | 0.007 | 0.1441 | 0.1441 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0951 | 0.0951 |
Mycobacterium ulcerans | hydrolase | 0.0042 | 0.0061 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 0.8162 | 0.8023 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0061 | 0.0061 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0078 | 0.1833 | 0.5 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0127 | 0.4262 | 0.3828 |
Brugia malayi | Fibulin-1 precursor | 0.0078 | 0.1833 | 0.854 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0951 | 0.0951 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0042 | 0.0061 | 0.0286 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0703 | 0.0703 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0241 | 1 | 1 |
Onchocerca volvulus | Arrow homolog | 0.007 | 0.1441 | 0.7427 |
Echinococcus multilocularis | fibrillin 1 | 0.0078 | 0.1833 | 0.1215 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0951 | 0.4431 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0703 | 0.3277 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0241 | 1 | 1 |
Echinococcus multilocularis | laminin | 0.0078 | 0.1833 | 0.1215 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0077 | 0.1799 | 1 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0078 | 0.1833 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0703 | 0.0703 |
Brugia malayi | Hemopexin family protein | 0.0049 | 0.0409 | 0.1905 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (binding) | = 56.2341 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.